Related Experiment Video
Updated: Jun 3, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
Effect of experimental glaucoma on the non-image forming visual system
Nuria de Zavalía1, Santiago A Plano, Diego C Fernandez
1Laboratorio de Neuroquímica Retiniana y Oftalmología Experimental, Departamento de Bioquímica Humana, Facultad de Medicina/CEFyBO, Universidad de Buenos Aires/CONICET, Paraguay, Buenos Aires, Argentina.
Glaucoma significantly impacts the non-image forming visual system, affecting melanopsin cells and light-driven melatonin production. This study reveals disruptions in circadian rhythms and pupil light reflexes in experimental glaucoma.
Area of Science:
- Neuroscience
- Ophthalmology
- Chronobiology
Background:
- Glaucoma is a primary cause of irreversible blindness globally.
- It involves retinal ganglion cell degeneration and optic nerve damage.
- The non-image forming visual system's role in glaucoma is not fully understood.
Purpose of the Study:
- To investigate the effects of experimental glaucoma on the non-image forming visual system in rats.
- To assess alterations in melanopsin expression, pupil light reflex, and circadian rhythms.
Main Methods:
- Experimental glaucoma was induced in rats via chondroitin sulphate (CS) injections into the anterior chamber.
- Retinal and superior collicular cell counts were performed.
- Pupil light reflex, melatonin levels, and c-Fos expression in suprachiasmatic nuclei were measured.
- Circadian activity patterns were analyzed.
Main Results:
- CS injections decreased melanopsin and Thy-1 levels and reduced melanopsin-containing cells.
- Experimental glaucoma impaired the pupil light reflex and altered light-induced melatonin suppression.
- Glaucomatous rats showed reduced light-induced c-Fos expression and altered activity patterns, including a delayed phase angle.
Conclusions:
- Experimental glaucoma significantly disrupts the non-image forming visual system.
- Alterations include changes in melanopsin pathways, circadian regulation, and light responsiveness.
- These findings highlight potential new therapeutic targets for glaucoma beyond intraocular pressure reduction.
Related Concept Videos
Glaucoma: Overview
Photoreceptors and Visual Pathways
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

